HLAA’s Externally-Led Patient Focused Drug Development Meeting: Voice of the Patient Report now available
The Hearing Loss Association of America (HLAA) received permission from the U.S. Food & Drug Administration (FDA) to hold an Externally-Led Patient-Focused Drug Development Meeting for People and Families Living with Sensorineural Hearing Loss (https://www.hearingloss.org/hlaa-pfdd/) on Tuesday, May 25, 2021.
This was a real opportunity to ensure patient engagement has a role in shaping future hearing loss treatments and creating a deeper understanding by FDA of the impact of hearing loss on individuals and their quality of life. The voice of those with hearing loss was certainly heard loud and clear!
The May 25 HLAA interactive virtual meeting had 411 unique views. There were 712 people who pre-registered for the meeting.
4 June 2021